|
Abiraterone in prostate cancer
The big news in oncology has been Johnson and Johnson purchasing Cougar Biotechnology for $1 billion. They have just bought promising prostate cancer compound, abiraterone.
So look out for this oral drug.
Dr.Shroff The data hasn't even been announced at ASCO yet, that's this weekend coming, so one can only speculate that suitors got a sneak peek of the data under an NDA. A billion dollars certainly gets attention and raises the ante for future small oncology biotech deals.
|
Replied on Monday, January 18, 2010 12:00 AM
|
|
|
(Guest)
what are the chances of prostate cancer after the age of 69yrs.
|
Replied on Sunday, July 30, 2017 12:08 PM
|
|
|
|